Therapies made from embryonic stem cells are showing promising early results in Parkinson's disease. Their main potential benefit is replacing the dopamine-producing neurons that the disease damages.
The immune system also plays an important role, affecting inflammation in the brain, how well transplanted cells survive, and how safe treatment is.
How the Immune System Is Involved
Unlike multiple sclerosis, Parkinson's is not generally classed as an autoimmune disease. However, long-term inflammation in the brain and abnormal immune activity may contribute to how the disease progresses.
Parkinson's involves the gradual loss of dopamine-producing neurons in an area of the brain called the substantia nigra. Several immune mechanisms may contribute to this process.
Why It Matters
Stem cell-derived therapies are one of the most exciting developments in Parkinson's care, with the potential to replace the dopamine-producing neurons the disease damages.
Talk to Our Team
If you or a family member is living with Parkinson's, our team can explain the latest research and help you understand your options alongside your neurologist.




